Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2023 17.75M
March 31, 2023 25.74M
December 31, 2022 38.31M
September 30, 2022 47.18M
June 30, 2022 56.58M
March 31, 2022 67.14M
December 31, 2021 80.73M
September 30, 2021 90.09M
June 30, 2021 97.41M
March 31, 2021 106.91M
December 31, 2020 34.26M
September 30, 2020 41.44M
June 30, 2020 42.73M
March 31, 2020 50.35M
December 31, 2019 42.44M
September 30, 2019 51.99M
June 30, 2019 63.00M
March 31, 2019 70.53M
December 31, 2018 58.59M
September 30, 2018 42.17M
June 30, 2018 49.16M
March 31, 2018 47.81M
December 31, 2017 57.61M
September 30, 2017 55.58M
June 30, 2017 66.71M
Date Value
March 31, 2017 75.93M
December 31, 2016 93.22M
September 30, 2016 112.80M
June 30, 2016 146.89M
March 31, 2016 192.97M
December 31, 2015 245.23M
September 30, 2015 162.96M
June 30, 2015 199.48M
March 31, 2015 233.05M
December 31, 2014 332.73M
September 30, 2014 379.00M
June 30, 2014 141.16M
March 31, 2014 171.53M
December 31, 2013 213.89M
September 30, 2013 250.30M
June 30, 2013 276.68M
March 31, 2013 302.57M
December 31, 2012 326.02M
September 30, 2012 188.77M
June 30, 2012 103.91M
March 31, 2012 104.29M
December 31, 2011 115.28M
September 30, 2011 74.61M
June 30, 2011 81.64M
March 31, 2011 90.52M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Adynxx, Inc. --
OncoSec Medical, Inc. --
Proteonomix, Inc. --
Rebus Holdings, Inc. --
Poniard Pharmaceuticals, Inc. --